Smith Karen L. 4
4 · Skye Bioscience, Inc. · Filed Jul 5, 2024
Insider Transaction Report
Form 4
Smith Karen L.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2024-07-02+40,000→ 40,000 totalExercise: $7.56Exp: 2034-07-01→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in equal monthly installments over the one year period from the date of grant.